UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Toxocariasis ocular congénita en un recién nacido prematuro

Anales de pediatría (Barcelona, Spain : 2003), 2006, Vol.64 (6), p.599-600

2006

Volltextzugriff (PDF)

Congenital ocular toxocariasis in a premature neonate

Anales de pediatría (Barcelona, Spain : 2003), 2006-06, Vol.64 (6), p.599

2006

Volltextzugriff (PDF)

Significative lengthening of the time of cornea conservation supporting its natural tension and curvature

Revista de la Facultad de Ciencias Médicas de Córdoba, 2000, Vol.57 (2), p.163

2000

Volltextzugriff (PDF)

Surgery of glaucoma: intrascleral trabeculo-irido encleisis

Revista de la Facultad de Ciencias Médicas de Córdoba, 1993, Vol.51 (1), p.13

Maffrand, R A

1993

Volltextzugriff (PDF)

Larva migrans syndrome or ocular toxocariasis

Revista de la Facultad de Ciencias Médicas de Córdoba, 2001, Vol.58 (1), p.99

2001

Volltextzugriff (PDF)

Toxoplasmic retinochoroiditis reactivated in the puberty

Revista de la Facultad de Ciencias Médicas de Córdoba, 2000, Vol.57 (2), p.249

2000

Volltextzugriff (PDF)

Congenital ocular toxocariasis in a premature neonate

Anales de pediatria (Barcelona, Spain : 2003), 2006, Vol.64 (6), p.599-600

2006

Volltextzugriff (PDF)

Observación biomicroscópica de los nervios de la cornea en la enfermedad de Hansen

Revista argentina de dermatosifilologia, 1945-12, Vol.29, p.303

MAFFRAND, R A

1945

Volltextzugriff (PDF)

Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice

American journal of physiology. Regulatory, integrative and comparative physiology, 2003-02, Vol.284 (2), p.345-R353

2003

Volltextzugriff (PDF)

4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1, 3-thiazol-2-amine hydrochloride (SSR125543A), a potent and selective corticotrophin-releasing factor(1) receptor antagonist. II. Characterization in rodent models of stress-related disorders

The Journal of pharmacology and experimental therapeutics, 2002-04, Vol.301 (1), p.333

2002

Volltextzugriff (PDF)

Biochemical and pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonist

The Journal of pharmacology and experimental therapeutics, 1997-02, Vol.280 (2), p.802

1997

Volltextzugriff (PDF)

Biochemical and Pharmacological Profile of a Potent and Selective Nonpeptide Antagonist of the Neurotensin Receptor

Proceedings of the National Academy of Sciences - PNAS, 1993-01, Vol.90 (1), p.65-69

1993

Volltextzugriff (PDF)

ADP Plays an Important Role in Mediating Platelet Aggregation and Cyclic Flow Variations In Vivo in Stenosed and Endothelium-Injured Canine Coronary Arteries

Circulation research, 1992-01, Vol.70 (1), p.39-48

1992

Volltextzugriff (PDF)

4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1,3-thiazol-2-amine hydrochloride (SSR125543A): a potent and selective corticotrophin-releasing factor(1) receptor antagonist. I. Biochemical and pharmacological characterization

The Journal of pharmacology and experimental therapeutics, 2002-04, Vol.301 (1), p.322

2002

Volltextzugriff (PDF)

Protective effects of SR 57746A in central and peripheral models of neurodegenerative disorders in rodents and primates

Neuroscience, 1993-08, Vol.55 (3), p.629-641

1993

Volltextzugriff (PDF)

Purification and characterization of the human SR 31747A-binding protein. A nuclear membrane protein related to yeast sterol isomerase

The Journal of biological chemistry, 1997-10, Vol.272 (43), p.27107-27115

1997

Volltextzugriff (PDF)

Effects of Divalent Cations and of a Calcimimetic on Adrenocorticotropic Hormone Release in Pituitary Tumor Cells

Biochemical and biophysical research communications, 1997-09, Vol.238 (3), p.866-873

1997

Volltextzugriff (PDF)

SR146131: a new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. II. In vivo pharmacological characterization

The Journal of pharmacology and experimental therapeutics, 1999-05, Vol.289 (2), p.752

1999

Volltextzugriff (PDF)

Neurotensin receptor interaction with dopaminergic systems in the guinea-pig brain shown by neurotensin receptor antagonists

European journal of pharmacology, 1994-04, Vol.255 (1), p.167-174

1994

Volltextzugriff (PDF)

Biochemical and pharmacological activities of SSR 146977, a new potent nonpeptide tachykinin NK3 receptor antagonist

Canadian journal of physiology and pharmacology, 2002-05, Vol.80 (5), p.482

2002

Volltextzugriff (PDF)

SR146131: a new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. I. In vitro studies

The Journal of pharmacology and experimental therapeutics, 1999-05, Vol.289 (2), p.742

1999

Volltextzugriff (PDF)

Broad spectrum anti-platelet activity of ticlopidine and PCR 4099 involves the suppression of the effects of released ADP

Thrombosis research, 1987-11, Vol.48 (4), p.403-415

1987

Volltextzugriff (PDF)

SSR240600 [(R)-2-(1-[2-[4-[2-[3,5-bis(trifluoromethyl)phenyl]acetyl]-2-(3,4-dichlorophenyl)-2-morpholinyl]ethyl]- 4-piperidinyl)-2-methylpropanamide], a centrally active nonpeptide antagonist of the tachykinin neurokinin-1 receptor: I. biochemical and pharmacological characterization

The Journal of pharmacology and experimental therapeutics, 2002-12, Vol.303 (3), p.1171-1179

2002

Volltextzugriff (PDF)

Effect of PCR 4099 on ADP-induced calcium movements and phosphatidic acid production in rat platelets

Biochemical pharmacology, 1988-07, Vol.37 (13), p.2559-2564

1988

Volltextzugriff (PDF)

Neuropharmacological profile of non-peptide neurotensin antagonists

Fundamental & clinical pharmacology, 1995-01, Vol.9 (6), p.513-521

1995

Volltextzugriff (PDF)

1 – 25 von 61

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(27)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Animals
(24)
Science & Technology
(24)
Life Sciences & Biomedicine
(19)
Humans
(17)
Biological And Medical Sciences
(14)
Male
(13)
Medical Sciences
(13)
Pharmacology. Drug Treatments
(12)
Rats
(12)
Pharmacology & Pharmacy
(11)
Female
(10)
Chemistry
(8)
Mice
(8)
Cho Cells
(6)
Cricetinae
(6)
Neuropharmacology
(6)
Organic Chemistry
(6)
Rabbits
(6)
Blood. Blood Coagulation. Reticuloendothelial System
(5)
Exact Sciences And Technology
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Toxocariasis ocular congénita en un recién nacido prematuro

Congenital ocular toxocariasis in a premature neonate

Significative lengthening of the time of cornea conservation supporting its natural tension and curvature

Surgery of glaucoma: intrascleral trabeculo-irido encleisis

Larva migrans syndrome or ocular toxocariasis

Toxoplasmic retinochoroiditis reactivated in the puberty

Congenital ocular toxocariasis in a premature neonate

Observación biomicroscópica de los nervios de la cornea en la enfermedad de Hansen

Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice

Biochemical and pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonist

Biochemical and Pharmacological Profile of a Potent and Selective Nonpeptide Antagonist of the Neurotensin Receptor

ADP Plays an Important Role in Mediating Platelet Aggregation and Cyclic Flow Variations In Vivo in Stenosed and Endothelium-Injured Canine Coronary Arteries

4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1,3-thiazol-2-amine hydrochloride (SSR125543A): a potent and selective corticotrophin-releasing factor(1) receptor antagonist. I. Biochemical and pharmacological characterization

Protective effects of SR 57746A in central and peripheral models of neurodegenerative disorders in rodents and primates

Purification and characterization of the human SR 31747A-binding protein. A nuclear membrane protein related to yeast sterol isomerase

Effects of Divalent Cations and of a Calcimimetic on Adrenocorticotropic Hormone Release in Pituitary Tumor Cells

SR146131: a new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. II. In vivo pharmacological characterization

Neurotensin receptor interaction with dopaminergic systems in the guinea-pig brain shown by neurotensin receptor antagonists

Biochemical and pharmacological activities of SSR 146977, a new potent nonpeptide tachykinin NK3 receptor antagonist

SR146131: a new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. I. In vitro studies

Broad spectrum anti-platelet activity of ticlopidine and PCR 4099 involves the suppression of the effects of released ADP

SSR240600 [(R)-2-(1-[2-[4-[2-[3,5-bis(trifluoromethyl)phenyl]acetyl]-2-(3,4-dichlorophenyl)-2-morpholinyl]ethyl]- 4-piperidinyl)-2-methylpropanamide], a centrally active nonpeptide antagonist of the tachykinin neurokinin-1 receptor: I. biochemical and pharmacological characterization

Effect of PCR 4099 on ADP-induced calcium movements and phosphatidic acid production in rat platelets

Neuropharmacological profile of non-peptide neurotensin antagonists

Suchergebnisse filtern